https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Study Finds HER2-Negative Outperforms HER2-Low in Neoadjuvant Chemotherapy Response in Breast Cancer

Study Finds HER2-Negative Outperforms HER2-Low in Neoadjuvant Chemotherapy Response in Breast Cancer

Research reveals HER2-negative breast cancer shows higher pCR rates than HER2-low, influencing neoadjuvant chemotherapy strategies for early-stage patients.

administrator

Related Articles